144 related articles for article (PubMed ID: 24170108)
21. Muscle insulin resistance in type 1 diabetes with coronary artery disease.
Williams KV; Shay CM; Price JC; Goodpaster BH; Kelley CA; Kelley DE; Orchard TJ
Diabetologia; 2020 Dec; 63(12):2665-2674. PubMed ID: 32926189
[TBL] [Abstract][Full Text] [Related]
22. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans.
Peltoniemi P; Lönnroth P; Laine H; Oikonen V; Tolvanen T; Grönroos T; Strindberg L; Knuuti J; Nuutila P
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1122-30. PubMed ID: 11052968
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of insulin resistance assessed by dynamic in-vivo positron emission tomography imaging.
Ng JM; Kelley DE; Goodpaster BH
Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):508-12. PubMed ID: 19550312
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
[TBL] [Abstract][Full Text] [Related]
25. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
Petersen KF; Dufour S; Shulman GI
PLoS Med; 2005 Sep; 2(9):e233. PubMed ID: 16089501
[TBL] [Abstract][Full Text] [Related]
26. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
27. Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjects.
Slimani L; Oikonen V; Hällsten K; Savisto N; Knuuti J; Nuutila P; Iozzo P
J Clin Endocrinol Metab; 2006 Sep; 91(9):3394-403. PubMed ID: 16772346
[TBL] [Abstract][Full Text] [Related]
28. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
29. Assessment of insulin resistance in the skeletal muscle of mice using positron emission tomography/computed tomography imaging.
Miyatake Y; Mishima Y; Tsutsumi R; Otani T; Suemasa N; Masumoto S; Kuroda M; Sakaue H
Biochem Biophys Res Commun; 2020 Jul; 528(3):499-505. PubMed ID: 32513534
[TBL] [Abstract][Full Text] [Related]
30. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans.
Ter Horst KW; Gilijamse PW; Ackermans MT; Soeters MR; Nieuwdorp M; Romijn JA; Serlie MJ
Metabolism; 2016 May; 65(5):757-763. PubMed ID: 27085782
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycemia-induced stimulation of glucose transport in skeletal muscle measured by PET-[18F]6FDG and [18F]2FDG.
Huang HM; Chandramouli V; Ismail-Beigi F; Muzic RF
Physiol Meas; 2012 Oct; 33(10):1661-73. PubMed ID: 22986442
[TBL] [Abstract][Full Text] [Related]
32. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
33. In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.
Minn H; Nuutila P; Lindholm P; Ruotsalainen U; Bergman J; Teräs M; Knuuti MJ
Cancer; 1994 Mar; 73(5):1490-8. PubMed ID: 8111717
[TBL] [Abstract][Full Text] [Related]
34. Effects of insulin on blood flow and volume in skeletal muscle of patients with IDDM: studies using [15O]H2O, [15O]CO, and positron emission tomography.
Raitakari M; Nuutila P; Knuuti J; Raitakari OT; Laine H; Ruotsalainen U; Kirvelä O; Takala TO; Iida H; Yki-Järvinen H
Diabetes; 1997 Dec; 46(12):2017-21. PubMed ID: 9392489
[TBL] [Abstract][Full Text] [Related]
35. Evidence for increased and insulin-resistant lipolysis in skeletal muscle of high-fat-fed rats.
Guo Z; Zhou L
Metabolism; 2004 Jun; 53(6):794-8. PubMed ID: 15164331
[TBL] [Abstract][Full Text] [Related]
36. Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers.
Rönnemaa EM; Rönnemaa T; Utriainen T; Raitakari M; Laine H; Takala T; Pitkänen OP; Kirvelä O; Knuuti J; Nuutila P
Metabolism; 1999 Feb; 48(2):239-44. PubMed ID: 10024089
[TBL] [Abstract][Full Text] [Related]
37. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
38. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
[TBL] [Abstract][Full Text] [Related]
39. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.
Selberg O; Burchert W; vd Hoff J; Meyer GJ; Hundeshagen H; Radoch E; Balks HJ; Müller MJ
J Clin Invest; 1993 May; 91(5):1897-902. PubMed ID: 8486761
[TBL] [Abstract][Full Text] [Related]
40. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ
Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
